How can companies foster a motivated, future-ready workforce while maintaining employee engagement and retention? What strategies can leaders employ to balance skill development with organizational growth?
We sat down with Jill O'Mullane, a pharmaceutical QA leader with 23 years of experience in global organizations, to explore these critical questions.
Based in the UK, Jill provides a firsthand look at the challenges and strategies of nurturing talent in highly regulated industries like pharmaceuticals. From building competency models to implementing mentoring programs, Jill and The FDA Group’s Nicholas Capman discuss steps leaders can take to create an environment that prioritizes people development, succession planning, and continuous learning.
With over two decades of experience in the pharmaceutical industry, Jill O'Mullane is a seasoned quality assurance leader known for her integrity, professionalism, and strategic approach to quality systems. Currently serving as Vice President, Head of Quality Systems at Astellas Pharma Europe, Jill oversees critical quality functions, ensuring compliance and operational excellence across the organization. An eligible Qualified Person (QP) under Directive 2001/83/EC, Jill has held various senior leadership roles at Astellas Pharma, including Vice President of Affiliate & Supply Chain QA and Executive Director of Affiliate QA.
Her career spans positions at renowned organizations like Lonza, Baxter Healthcare, and Genzyme, where she honed her expertise in GMP, CAPA, and quality operations on a global scale. A graduate of University College Cork with a BSc in Biochemistry, Jill is passionate about fostering innovation in quality assurance and mentoring future leaders.